Skip to content
Wednesday, July 15, 2026
Canada's Leading Online Business Magazine
X-twitter
Search
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
×
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
×
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
Home
CBJ Newsmakers
Quantum Biopharma Announces Appointment of Principal Investigator for Planned Phase 2 Clinical Trial of Lucid-21-302 (Lucid-MS) in Multiple Sclerosis
Quantum Biopharma Announces Appointment of Principal Investigator for Planned Phase 2 Clinical Trial of Lucid-21-302 (Lucid-MS) in Multiple Sclerosis
CBJ Newsmakers
Recommended
Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program
Cognitrex Inc. Announces Market Entry of Enterprise LearningOS Platform Led by Founder Hana Dhanji
Bombardier to Provide Six Multi-role Aircraft to Support the Royal Canadian Air Force
